Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Radiol Cardiothorac Imaging ; 3(6): e210217, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-34934950

RESUMO

Cardiac MRI is clinically feasible in the setting of submassive pulmonary embolism and is able to demonstrate measurable differences of right heart function before and after catheter-directed therapy.

3.
Proc Natl Acad Sci U S A ; 112(28): 8726-31, 2015 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-26124113

RESUMO

Defining the signaling network that controls reactive astrogliosis may provide novel treatment targets for patients with diverse CNS injuries and pathologies. We report that the radial glial cell antigen RC2 identifies the majority of proliferating glial fibrillary acidic protein-positive (GFAP(+)) reactive astrocytes after stroke. These cells highly expressed endothelin receptor type B (ETB(R)) and Jagged1, a Notch1 receptor ligand. To study signaling in adult reactive astrocytes, we developed a model based on reactive astrocyte-derived neural stem cells isolated from GFAP-CreER-Notch1 conditional knockout (cKO) mice. By loss- and gain-of-function studies and promoter activity assays, we found that Jagged1/Notch1 signaling increased ETB(R) expression indirectly by raising the level of phosphorylated signal transducer and activator of transcription 3 (STAT3), a previously unidentified EDNRB transcriptional activator. Similar to inducible transgenic GFAP-CreER-Notch1-cKO mice, GFAP-CreER-ETB(R)-cKO mice exhibited a defect in reactive astrocyte proliferation after cerebral ischemia. Our results indicate that the Notch1-STAT3-ETB(R) axis connects a signaling network that promotes reactive astrocyte proliferation after brain injury.


Assuntos
Astrócitos/patologia , Lesões Encefálicas/patologia , Proliferação de Células , Receptor de Endotelina B/metabolismo , Receptor Notch1/metabolismo , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais , Animais , Astrócitos/metabolismo , Lesões Encefálicas/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Regiões Promotoras Genéticas , Receptor de Endotelina B/genética
4.
J Neurosci ; 32(23): 7926-40, 2012 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-22674268

RESUMO

In response to stroke, subpopulations of cortical reactive astrocytes proliferate and express proteins commonly associated with neural stem/progenitor cells such as glial fibrillary acidic protein (GFAP) and Nestin. To examine the stem cell-related properties of cortical reactive astrocytes after injury, we generated GFAP-CreER(TM);tdRFP mice to permanently label reactive astrocytes. We isolated cells from the cortical peri-infarct area 3 d after stroke, and cultured them in neural stem cell medium containing epidermal growth factor and basic fibroblast growth factor. We observed tdRFP-positive neural spheres in culture, suggestive of tdRFP-positive reactive astrocyte-derived neural stem/progenitor cells (Rad-NSCs). Cultured Rad-NSCs self-renewed and differentiated into neurons, astrocytes, and oligodendrocytes. Pharmacological inhibition and conditional knock-out mouse studies showed that Presenilin 1 and Notch 1 controlled neural sphere formation by Rad-NSCs after stroke. To examine the self-renewal and differentiation potential of Rad-NSCs in vivo, Rad-NSCs were transplanted into embryonic, neonatal, and adult mouse brains. Transplanted Rad-NSCs were observed to persist in the subventricular zone and secondary Rad-NSCs were isolated from the host brain 28 d after transplantation. In contrast with neurogenic postnatal day 4 NSCs and adult NSCs from the subventricular zone, transplanted Rad-NSCs differentiated into astrocytes and oligodendrocytes, but not neurons, demonstrating that Rad-NSCs had restricted differentiation in vivo. Our results indicate that Rad-NSCs are unlikely to be suitable for neuronal replacement in the absence of genetic or epigenetic modification.


Assuntos
Astrócitos/fisiologia , Córtex Cerebral/citologia , Córtex Cerebral/fisiologia , Infarto Cerebral/patologia , Células-Tronco Neurais/fisiologia , Acidente Vascular Cerebral/patologia , Animais , Antimetabólitos/farmacologia , Western Blotting , Bromodesoxiuridina/farmacologia , Contagem de Células , Diferenciação Celular/fisiologia , Linhagem da Célula , Corantes , Citometria de Fluxo , Proteína Glial Fibrilar Ácida/metabolismo , Imuno-Histoquímica , Infarto da Artéria Cerebral Média/patologia , Proteínas Luminescentes/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Células-Tronco Neurais/transplante , Presenilina-1/antagonistas & inibidores , Presenilina-1/genética , Reação em Cadeia da Polimerase em Tempo Real , Receptor Notch1/antagonistas & inibidores , Receptor Notch1/genética , Transplante de Células-Tronco , Proteína Vermelha Fluorescente
5.
Pain ; 137(2): 395-404, 2008 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-17977662

RESUMO

Tolerance to the anti-nociceptive effects of opioids develops rapidly in animals. In contrast, humans with chronic pain show little or no loss of pain relief in prospective opioid trials of 4-8 weeks duration. Employing the Brief Thermal Sensitization model to induce transient cutaneous secondary hyperalgesia, we tested the hypothesis that opioid analgesic tolerance would develop rapidly. In this outpatient randomized placebo-controlled study, subjects in the MMMMP group received two injections of subcutaneous morphine 6 mg (150 min apart) on Monday-Thursday (total 48 mg over 4 days) and matching saline placebo on Friday. Subjects in the PPPPM group received placebo on Monday-Thursday and morphine (total 12 mg) on Friday. Sixty-one healthy volunteers were enrolled; morphine side effects accounted for all nine non-completions. Compared to the first placebo day, the reduction in the area of secondary hyperalgesia on the first morphine day was significant and robust in both groups. Morphine suppression of the painfulness of skin heating and elevation of the heat pain detection threshold were also significant. During 4 days of twice-daily injections, the decline in anti-hyperalgesic effects of morphine did not reach statistical significance (p=0.06) compared to placebo. Morphine side effects did not correlate with anti-hyperalgesic effects and withdrawal symptoms did not emerge. As 4 days is the threshold for demonstrating analgesic tolerance to twice-daily morphine in animal models, a longer period of opioid exposure in healthy volunteers might be needed to detect analgesic tolerance.


Assuntos
Analgesia/métodos , Analgésicos Opioides/administração & dosagem , Tolerância a Medicamentos/fisiologia , Morfina/administração & dosagem , Dor/tratamento farmacológico , Adulto , Analgésicos Opioides/efeitos adversos , Esquema de Medicação , Feminino , Humanos , Hiperalgesia/induzido quimicamente , Hiperalgesia/fisiopatologia , Injeções Subcutâneas , Masculino , Pessoa de Meia-Idade , Morfina/efeitos adversos , Nociceptores/efeitos dos fármacos , Nociceptores/fisiopatologia , Medição da Dor/efeitos dos fármacos , Efeito Placebo , Placebos , Valores de Referência , Células Receptoras Sensoriais/efeitos dos fármacos , Células Receptoras Sensoriais/fisiopatologia , Síndrome de Abstinência a Substâncias/fisiopatologia , Fatores de Tempo
6.
Dev Dyn ; 235(2): 411-26, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16331645

RESUMO

Notch signaling is used to specify cell types during animal development. A high level specifies one cell type, whereas a low level specifies the alternate type. The effector of Notch signaling is the Notch intracellular domain. Upon its release from the plasma membrane in response to Delta binding the Notch extracellular domain, the Notch intracellular domain combines with the transcription factor Suppressor of Hairless and promotes the expression of target genes. Using a panel of antibodies made against different extracellular and intracellular regions of Notch, we show that cell types and tissues with low levels of Notch signaling are enriched for Notch molecules detected only by the extracellular domain antibodies. This enrichment often follows enrichment for Notch molecules detected only by antibodies made against the Suppressor of Hairless binding region. Notch molecules lacking most of the intracellular domain or containing only the Suppressor of Hairless binding region are produced during development. Such molecules are known to suppress Notch signaling, possibly by taking away Delta or Suppressor of Hairless from the full-length Notch. Thus, it is possible that dominant-negative Notch molecules are produced in the normal course of tissue differentiation in Drosophila as part of an auto-down-regulation mechanism.


Assuntos
Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/embriologia , Drosophila melanogaster/metabolismo , Genes Dominantes/genética , Mutação/genética , Receptores Notch/genética , Receptores Notch/metabolismo , Animais , Animais Geneticamente Modificados , Anticorpos/imunologia , Fatores de Transcrição Hélice-Alça-Hélice Básicos/genética , Diferenciação Celular , Sistema Nervoso Central/citologia , Sistema Nervoso Central/embriologia , Sistema Nervoso Central/metabolismo , Proteínas de Drosophila/imunologia , Drosophila melanogaster/citologia , Drosophila melanogaster/genética , Epitopos/imunologia , Regulação da Expressão Gênica no Desenvolvimento/genética , Receptores Notch/imunologia , Transdução de Sinais/genética
7.
BMC Dev Biol ; 5: 6, 2005 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-15760463

RESUMO

BACKGROUND: Delta, Notch, and Scabrous often function together to make different cell types and refine tissue patterns during Drosophila development. Delta is known as the ligand that triggers Notch receptor activity. Scabrous is known to bind Notch and promote Notch activity in response to Delta. It is not known if Scabrous binds Delta or Delta has activity other than its activity as a ligand of Notch. It is very difficult to clearly determine this binding or activity in vivo as all Notch, Delta, and Scabrous activities are required simultaneously or successively in an inter-dependent manner. RESULTS: Using Drosophila cultured cells we show that the full length Delta promotes accumulation of Daughterless protein, fringe RNA, and pangolin RNA in the absence of Scabrous or Notch. Scabrous binds Delta and suppresses this activity even though it increases the level of the Delta intracellular domain. We also show that Scabrous can promote Notch receptor activity, in the absence of Delta. CONCLUSION: Delta has activity that is independent of its activity as a ligand of Notch. Scabrous suppresses this Delta activity. Scabrous also promotes Notch activity that is dependent on Delta's ligand activity. Thus, Notch, Delta, and Scabrous might function in complex combinatorial or mutually exclusive interactions during development. The data reported here will be of significant help in understanding these interactions in vivo.


Assuntos
Proteínas de Drosophila/fisiologia , Drosophila melanogaster/embriologia , Glicoproteínas/metabolismo , Proteínas de Membrana/fisiologia , Receptores Notch/fisiologia , Animais , Northern Blotting , Western Blotting , Linhagem Celular , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila melanogaster/citologia , Drosophila melanogaster/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Genes Controladores do Desenvolvimento , Genes de Insetos , Glicoproteínas/genética , Peptídeos e Proteínas de Sinalização Intracelular , Ligantes , Proteínas de Membrana/genética , N-Acetilglucosaminiltransferases/genética , N-Acetilglucosaminiltransferases/fisiologia , Análise de Sequência com Séries de Oligonucleotídeos , Ligação Proteica , RNA/genética , Receptores Notch/genética , Proteínas Repressoras/genética , Proteínas Repressoras/fisiologia , Fatores de Transcrição/genética , Fatores de Transcrição/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...